SCHEMBL3368235

SCHEMBL3368235

COc1cc(O)c2c(c1)OC(c1ccc(O)cc1)C(=O)C2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 8/20 0.53
ALDH1A1 P00352 2/20 0.53
MAPT P10636 2/20 0.53
ATM Q13315 2/20 0.53
ADORA3 P0DMS8 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
TAS2R31 P59538 1/20 0.53
ABCG2 Q9UNQ0 1/20 0.44
CBS P35520 1/20 0.43
ELAVL3 Q14576 1/20 0.42
CYP1A1 P04798 2/20 0.41
CYP1A2 P05177 2/20 0.41
CYP1B1 Q16678 2/20 0.41
CYP3A4 P08684 3/20 0.40
MAPK1 P28482 2/20 0.40
TP53 P04637 2/20 0.40
XDH P47989 2/20 0.40
HPGD P15428 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
PKM P14618 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27974387 0.95 CYP19A1 (0.47) CYP19A1ALDH1A1MAPTATMADORA3
SCHEMBL3364490 0.91 ABCG2 (0.54) CYP19A1ALDH1A1MAPTATMADORA3
SCHEMBL6503937 0.90 CYP19A1 (0.49) CYP19A1ALDH1A1MAPTATMADORA3
SCHEMBL5085611 0.90 CYP3A4 (0.49) CYP19A1ALDH1A1MAPTATMADORA3
SCHEMBL14829729 0.89 CYP19A1 (0.52) CYP19A1ALDH1A1MAPTATMADORA3
SCHEMBL7200862 0.89 CYP1A1 (0.54) CYP19A1ALDH1A1MAPTATMADORA3
SCHEMBL349722 0.85 CYP3A4 (0.52) CYP19A1ALDH1A1MAPTADORA3TDP1
SCHEMBL3487578 0.85 CYP3A4 (0.52) CYP19A1ALDH1A1MAPTADORA3TDP1
SCHEMBL27775453 0.82 NPC1 (0.44) CYP19A1ALDH1A1MAPTATMADORA3
SCHEMBL28710319 0.82 CYP19A1 (0.53) CYP19A1ALDH1A1MAPTATMADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893173-B1 AMINO-OXO-INDOLE-YLIDENE COMPOUNDS FOR USE IN TREATING SCALP SKIN ITCHING UNILEVER PLC (GB) 2010-10-06 EP claimed
US-20080207928-A1 Hair and/or Scalp Care Compositions Incorporating Flavonoid Compounds CONOPCO, INC. D/B/A UNILEVER 2008-08-28 US claimed
EP-1893173-A1 HAIR AND/OR SCALP CARE COMPOSITIONS INCORPORATING AMINO-OXO-INDOLE-YLIDENE COMPOUNDS Unilever Plc (GB) 2008-03-05 EP claimed
WO-2006097191-A1 HAIR AND/OR SCALP CARE COMPOSITIONS INCORPORATING FLAVONOID COMPOUNDS UNILEVER PLC (GB) 2006-09-21 WO claimed
US-4617293-A Flavonoid phosphate salts of aminoglycoside antibiotics MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 1986-10-14 US claimed
CN-107753542-B South American wedelia chinensis antioxidant extract and preparation method and application thereof 海南师范大学 2021-05-07 CN disclosed
US-9434908-B2 Method for extracting an odorous extract by an alternative solvent to conventional solvents CHARABOT (FR) 2016-09-06 US disclosed
EP-1893173-B1 AMINO-OXO-INDOLE-YLIDENE COMPOUNDS FOR USE IN TREATING SCALP SKIN ITCHING UNILEVER PLC (GB) 2010-10-06 EP disclosed
EP-2082726-A2 Hair and/or scalp care compositions incorporating flavonoid compounds Unilever PLC (GB) 2009-07-29 EP disclosed
US-20080287374-A1 BREAST CANCER-RESISTANT PROTEIN INHIBITOR KABUSHIKI KAISHA YAKULT HONSHA (JP) 2008-11-20 US disclosed
US-20080207928-A1 Hair and/or Scalp Care Compositions Incorporating Flavonoid Compounds CONOPCO, INC. D/B/A UNILEVER 2008-08-28 US disclosed
EP-1893173-A1 HAIR AND/OR SCALP CARE COMPOSITIONS INCORPORATING AMINO-OXO-INDOLE-YLIDENE COMPOUNDS Unilever Plc (GB) 2008-03-05 EP disclosed
WO-2006097191-A1 HAIR AND/OR SCALP CARE COMPOSITIONS INCORPORATING FLAVONOID COMPOUNDS UNILEVER PLC (GB) 2006-09-21 WO disclosed
US-20060135445-A1 Breast cancer-resistant protein inhibitor KABUSHIKI KAISHA YAKULT HONSHA (JP) 2006-06-22 US disclosed
US-20030166583-A1 Such as epicatechin coadministered with retinoic acid; bioavailability HU, OLIVER YOA-PU (TW) 2003-09-04 US disclosed
EP-1286706-A2 GAMMA IRRADIATION OF PROTEIN-BASED PHARMACEUTICAL PRODUCTS The American National Red Cross (US) 2003-03-05 EP disclosed
WO-2001087357-A2 GAMMA IRRADIATION OF PROTEIN-BASED PHARMACEUTICAL PRODUCTS THE AMERICAN NATIONAL RED CROSS (US) 2001-11-22 WO disclosed
US-4617293-A Flavonoid phosphate salts of aminoglycoside antibiotics MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 1986-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135445-A1 Breast cancer-resistant protein inhibitor ABCC1, BCR, BRCA1 CYP19A1 145/4885ALDH1A1 1671/4885MAPT 3303/4885
US-20080287374-A1 BREAST CANCER-RESISTANT PROTEIN INHIBITOR ABCC1, BCR, BRCA1 CYP19A1 145/4885ALDH1A1 1671/4885MAPT 3303/4885
US-20030166583-A1 Such as epicatechin coadministered with retinoic acid; bioavailability CYP51A1, CYP2E1, CYP7A1 CYP19A1 29/4885ALDH1A1 126/4885MAPT 3874/4885
US-20080207928-A1 Hair and/or Scalp Care Compositions Incorporating Flavonoid Compounds POLR1C, F3, AKR1C3 CYP19A1 25/4885ALDH1A1 528/4885MAPT 2140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.